1. World Health Organization. Iron deficiency anemia—assessment, prevention, and control. A guide for program managers. 2001. Report No.: Document WHO/NHD/01.3.
2. Adamson JW. Iron deficiency and other hypoproliferative anemias. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill Companies; 2013. p. 844–51.
3. Neiser S, Wilhelm M, Schwarz K, Funk F, Geisser P, Burckhardt S. Assessment of dextran antigenicity of intravenous iron products by an immunodiffusion assay. Prot Nephrol Hypert. 2011;25:219–24.
4. Neiser S, Koskenkorva TS, Schwarz K, Wilhelm M, Burckhardt S. Assessment of dextran antigenicity of intravenous iron preparations with enzyme-linked immunosorbent assay (ELISA). Int J Mol Sci. 2016;17:1185–94.
5. Girelli D, Ugolini S, Busti F, Marchi G, Castagna A. Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol. 2018;107:16–30.